基于新型微球的方法用于检测和分型 46 种黏膜型人乳头瘤病毒。
Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types.
机构信息
National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
出版信息
J Clin Microbiol. 2012 Feb;50(2):460-4. doi: 10.1128/JCM.06090-11. Epub 2011 Nov 23.
Abstract
We have developed a novel microsphere-based genotyping method for 46 mucosal human papillomavirus (HPV) types. HPV DNA was amplified by PCR using general primers and typed by hybridization to HPV type-specific probes coupled to sortable microspheres based on the Luminex xMAP technology. Hybridization to each probe was specific for each HPV type without cross-hybridization and sensitive enough to allow typing of HPV contained in clinical specimens. The method was validated with direct sequencing and the Roche Linear Array genotyping method.
摘要
我们开发了一种新的基于微球的 46 种黏膜型人乳头瘤病毒（HPV）分型方法。HPV DNA 通过使用通用引物的 PCR 扩增，并通过与 HPV 型特异性探针的杂交进行分型，这些探针连接到基于 Luminex xMAP 技术的可分选微球上。与每个探针的杂交是针对每个 HPV 型的，没有交叉杂交，并且足够灵敏，可以对临床标本中包含的 HPV 进行分型。该方法通过直接测序和罗氏线性阵列基因分型方法进行了验证。
相似文献
1
Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types.
J Clin Microbiol. 2012 Feb;50(2):460-4. doi: 10.1128/JCM.06090-11. Epub 2011 Nov 23.
2
Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.
J Clin Microbiol. 2011 Oct;49(10):3560-7. doi: 10.1128/JCM.01173-11. Epub 2011 Aug 10.
3
Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes.
J Clin Microbiol. 2011 Oct;49(10):3474-81. doi: 10.1128/JCM.05039-11. Epub 2011 Aug 10.
4
A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay.
J Clin Microbiol. 2013 Apr;51(4):1171-8. doi: 10.1128/JCM.02831-12. Epub 2013 Jan 30.
5
Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods.
J Med Microbiol. 2011 Feb;60(Pt 2):162-171. doi: 10.1099/jmm.0.021642-0. Epub 2010 Oct 21.
6
Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
J Clin Microbiol. 2012 Jul;50(7):2359-65. doi: 10.1128/JCM.00337-12. Epub 2012 Apr 18.
7
Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR.
J Clin Microbiol. 2011 Nov;49(11):3977-9. doi: 10.1128/JCM.05646-11. Epub 2011 Sep 21.
8
Detection and typing of human papillomavirus by single hybridization.
J Virol Methods. 1995 Jan;51(1):115-24. doi: 10.1016/0166-0934(94)00152-7.
9
Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.
J Clin Microbiol. 2011 May;49(5):1899-906. doi: 10.1128/JCM.00235-10. Epub 2011 Feb 23.
10
An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
J Clin Virol. 2009 Jul;45 Suppl 1:S93-7. doi: 10.1016/S1386-6532(09)70014-9.
引用本文的文献
1
Identification of circulating human papillomavirus types through high-throughput sequencing of Canadian municipal and institutional wastewater samples.
Appl Environ Microbiol. 2025 Jul 23;91(7):e0034825. doi: 10.1128/aem.00348-25. Epub 2025 Jun 5.
2
High prevalence of vaccine-preventable anal human papillomavirus infections is associated with HIV infection among gay, bisexual, and men who have sex with men in Nairobi, Kenya.
Cancer Med. 2023 Jun;12(12):13745-13757. doi: 10.1002/cam4.6008. Epub 2023 May 4.
3
Distribution of HPV genotypes among women with abnormal cytology results in Alberta, Canada.
J Assoc Med Microbiol Infect Dis Can. 2021 Jul 20;6(2):94-103. doi: 10.3138/jammi-2020-0048. eCollection 2021 Jun.
4
HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada.
Sci Rep. 2021 Feb 26;11(1):4779. doi: 10.1038/s41598-021-84079-y.
5
Self-Collected Specimens Revealed a Higher Vaccine- and Non-Vaccine-Type Human Papillomavirus Prevalences in a Cross-Sectional Study in Akuse.
Adv Prev Med. 2020 Jan 22;2020:8343169. doi: 10.1155/2020/8343169. eCollection 2020.
6
Human papilloma virus genotypes in dysplasia and epithelial hyperplasia of oral cavity using the luminex xmap technology. A multicenter study.
Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25(1):e61-e70. doi: 10.4317/medoral.23188.
7
Isolation of Biopsy-Derived, Human Cervical Keratinocytes Propagated as Monolayer and Organoid Cultures.
Sci Rep. 2018 Dec 14;8(1):17869. doi: 10.1038/s41598-018-36150-4.
8
HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma.
Papillomavirus Res. 2018 Dec;6:1-5. doi: 10.1016/j.pvr.2018.05.003. Epub 2018 May 26.
9
Type-specific human papillomavirus infections and Pap test findings in Inuit and non-Inuit women in Nunavut, Canada.
Can Commun Dis Rep. 2015 Mar 5;41(3):43-51. doi: 10.14745/ccdr.v41i03a01.
10
Differences in age-specific HPV prevalence between self-collected and health personnel collected specimen in a cross-sectional study in Ghana.
Infect Agent Cancer. 2017 May 18;12:26. doi: 10.1186/s13027-017-0136-7. eCollection 2017.
本文引用的文献
1
Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study.
BMJ Open. 2011 Feb 26;1(1):e000030. doi: 10.1136/bmjopen-2010-000030.
2
Commercially available assays for multiplex detection of alpha human papillomaviruses.
Expert Rev Anti Infect Ther. 2010 Oct;8(10):1139-62. doi: 10.1586/eri.10.104.
3
Global proficiency study of human papillomavirus genotyping.
J Clin Microbiol. 2010 Nov;48(11):4147-55. doi: 10.1128/JCM.00918-10. Epub 2010 Sep 15.
4
Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
J Clin Virol. 2009 Oct;46(2):176-9. doi: 10.1016/j.jcv.2009.07.017. Epub 2009 Aug 15.
5
A review of human carcinogens--Part B: biological agents.
Lancet Oncol. 2009 Apr;10(4):321-2. doi: 10.1016/s1470-2045(09)70096-8.
6
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019.
7
Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.
Vaccine. 2008 Aug 19;26 Suppl 10(0 10):K17-28. doi: 10.1016/j.vaccine.2008.06.021.
8
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Vaccine. 2008 Aug 19;26 Suppl 10:K1-16. doi: 10.1016/j.vaccine.2008.05.064.
9
Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test.
J Clin Microbiol. 2007 Nov;45(11):3821-3. doi: 10.1128/JCM.01145-07. Epub 2007 Sep 26.
10
Case-control study of human papillomavirus and oropharyngeal cancer.
N Engl J Med. 2007 May 10;356(19):1944-56. doi: 10.1056/NEJMoa065497.
Zotero 插件